6.
Alanazi A, Alsadhan S, Aldosari S, Alharbi A, Albawardi M, Alrabah S
. Prevalence and Correlation of Metabolic Syndrome in Patients with Bipolar Disorder in NGHA, Riyadh. Biomed Res Int. 2022; 2022:5847175.
PMC: 9314176.
DOI: 10.1155/2022/5847175.
View
7.
Merikangas K, Jin R, He J, Kessler R, Lee S, Sampson N
. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011; 68(3):241-51.
PMC: 3486639.
DOI: 10.1001/archgenpsychiatry.2011.12.
View
8.
Chu C, Liang C
. Mood state as a blood glucose modulator in a patient with bipolar disorder and diabetes mellitus: A case report. Aust N Z J Psychiatry. 2018; 52(10):1004-1005.
DOI: 10.1177/0004867418787643.
View
9.
Abdul Karim M, Al-Baz N, Ouanes S, Khalil A, Assar A, Alsiddiqi A
. Quality of diabetes care in patients with schizophrenia: a case-control study in Qatar. BMC Psychiatry. 2021; 21(1):149.
PMC: 7953779.
DOI: 10.1186/s12888-021-03121-5.
View
10.
Garrett C, Doherty A
. Diabetes and mental health. Clin Med (Lond). 2014; 14(6):669-72.
PMC: 4954143.
DOI: 10.7861/clinmedicine.14-6-669.
View
11.
Lieberman 3rd J
. Metabolic changes associated with antipsychotic use. Prim Care Companion J Clin Psychiatry. 2005; 6(Suppl 2):8-13.
PMC: 487012.
View
12.
Bauer M, Pfennig A
. Epidemiology of bipolar disorders. Epilepsia. 2005; 46 Suppl 4:8-13.
DOI: 10.1111/j.1528-1167.2005.463003.x.
View
13.
Liu Y, Ling S, Lui L, Ceban F, Vinberg M, Kessing L
. Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis. J Affect Disord. 2021; 300:449-461.
DOI: 10.1016/j.jad.2021.12.110.
View
14.
Vancampfort D, Vansteelandt K, Correll C, Mitchell A, De Herdt A, Sienaert P
. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013; 170(3):265-74.
DOI: 10.1176/appi.ajp.2012.12050620.
View
15.
Lieberman J, Stroup T, McEvoy J, Swartz M, Rosenheck R, Perkins D
. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12):1209-23.
DOI: 10.1056/NEJMoa051688.
View
16.
Fitzgerald I, OConnell J, Keating D, Hynes C, McWilliams S, Crowley E
. Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology. Evid Based Ment Health. 2021; 25(1):15-22.
PMC: 8788031.
DOI: 10.1136/ebmental-2021-300291.
View
17.
Siegel-Ramsay J, Sharp S, Ulack C, Chiang K, Lanza di Scalea T, OHara S
. Experiences that matter in bipolar disorder: a qualitative study using the capability, comfort and calm framework. Int J Bipolar Disord. 2023; 11(1):13.
PMC: 10119352.
DOI: 10.1186/s40345-023-00293-9.
View
18.
McIntyre R, Nguyen H, Soczynska J, Lourenco M, Woldeyohannes H, Konarski J
. Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities. Dialogues Clin Neurosci. 2008; 10(2):203-13.
PMC: 3181869.
View
19.
Le T, Dao X, Nguyen D, Luu D, Bui T, Le T
. Insulin signaling and its application. Front Endocrinol (Lausanne). 2023; 14:1226655.
PMC: 10469844.
DOI: 10.3389/fendo.2023.1226655.
View
20.
Kontoangelos K, Raptis A, Papageorgiou C, Papadimitriou G, Rabavilas A, Dimitriadis G
. The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: new insights. Int J Psychiatry Clin Pract. 2012; 17(1):48-55.
DOI: 10.3109/13651501.2012.697563.
View